DE:HG6 Stock Latest News
Company AnnouncementsMayne Pharma Reports AGM Voting Outcome and Remuneration-Report First Strike22h ago
Company AnnouncementsMayne Pharma Details 2026 Annual General Meeting1d ago
Company AnnouncementsMayne Pharma AGM: Dr Brett Wells election resolution withdrawn3d ago
Company AnnouncementsMayne Pharma Enters Scheme Deed With Gedeon Richter4d ago
Company AnnouncementsMayne Pharma Provides AGM Updates on Election and Proxies4d ago
Company AnnouncementsMayne Pharma Announces Divestment of International Business2w agoCompany AnnouncementsMayne Pharma Issues 444,346 Unquoted Performance Rights Under Incentive Scheme3w ago
Company AnnouncementsMayne Pharma Issues Over 1.2 Million Unquoted Performance Rights Under Incentive Scheme3w ago
Company AnnouncementsMayne Pharma details use of non‑IFRS metrics and risk framework in investor update3w ago
Company AnnouncementsMayne Pharma Leans Into Women’s Health as Legal Clarity and Investments Hit Short-Term Earnings3w ago
Company AnnouncementsMayne Pharma Sets Hybrid 2026 AGM to Vote on Governance and Incentive Plan1M ago
Company AnnouncementsMayne Pharma wins appeal in Cosette deal dispute, strengthens legal position1M agoCompany AnnouncementsFDA clears IMVEXXY post-marketing obligations as Mayne Pharma targets U.S. menopause growth1M ago
Company AnnouncementsMayne Pharma Secures Long-Term IMVEXXY Patent Protection in U.S. Settlement With Sun Pharma1M ago
Company AnnouncementsMayne Pharma Reaches Low-Cost Settlement With U.S. States Over Generic Drug Probe1M ago
Company AnnouncementsMayne Pharma Sets Date for 2026 Annual General Meeting1M ago
Company AnnouncementsMayne Pharma Secures Exclusive Australian Rights to Menopause Therapy Blissel2M ago
Company AnnouncementsMayne Pharma Cancels Tranche of Performance Rights in Capital Management Move2M agoCompany AnnouncementsMayne Pharma Issues New Shares Following Conversion of Unquoted Securities2M ago

